Dr. Michael Auerbach, MD

Dr. Auerbach practices at Auerbach Hematology Oncology Associates P C in Rosedale, Maryland.

Dr. Auerbach's NPI, 1336199942, was assigned on May 12, 2006. Dr. Auerbach graduated from New York Medical College in 1978. Dr. Auerbach holds Maryland license D0033551.

Dr. Auerbach's primary practice is Auerbach Hematology Oncology Associates P C, at 5233 King Ave, Rosedale, MD 21237 in Baltimore County. The practice phone is (410) 780-4050.

Dr. Auerbach's primary practice is Auerbach Hematology Oncology Associates P C in Rosedale, Maryland. Dr. Auerbach is also affiliated with MedStar Franklin Square Medical Center. The medical group on file is Zangmeister Cancer Center. Dmand AI also links Dr. Auerbach to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Auerbach practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Auerbach's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Auerbach is licensed in Maryland.

CMS data shows 89,307 Medicare services from Dr. Auerbach across 22 procedure codes in 2024, for 546 Medicare patients. Medicare paid $722,202 for them. Every service was in an office.

CMS counts 546 Medicare patients who saw Dr. Auerbach in 2024. The largest group is 65 to 74, with 226 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Auerbach's median patient age at 65, with 66% women.

In 2024, Dr. Auerbach wrote 365 Medicare Part D claims for 85 patients. 71% of them were for generic drugs. CMS names the drug for 251 of them, across 11 drugs with 11 or more claims each, at $1,329,740 in total drug cost. In 2023, CMS named 226 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Auerbach for performance year 2024, reported individually. Dr. Auerbach accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 90 papers to Dr. Auerbach, published from 2004 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Anemia, Iron-Deficiency, Iron and Anemia. Dr. Auerbach has published most often in Am J Hematol. Dr. Auerbach's most frequent co-authors are Richard J. Derman, MD, Aryeh Shander, MD and John W. Adamson, MD.

Dmand AI links Dr. Auerbach to 1 clinical trial. Conditions studied include Restless Legs Syndrome and Anemia, Iron-Deficiency.

CMS Open Payments shows 1,357 general payments to Dr. Auerbach from 79 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Pharmacosmos Therapeutics Inc. paid the most, $39,355.

Dr. Auerbach graduated from New York Medical College in 1978.